『JAMA Otolaryngology–Head & Neck Surgery Author Interviews』のカバーアート

JAMA Otolaryngology–Head & Neck Surgery Author Interviews

JAMA Otolaryngology–Head & Neck Surgery Author Interviews

著者： JAMA Network
無料で聴く

このコンテンツについて

 Interviews with authors of articles from JAMA Otolaryngology–Head & Neck Surgery. JAMA Otolaryngology–Head & Neck Surgery is a peer-reviewed medical journal that provides timely information for physicians and scientists concerned with diseases of the head and neck. Given the diversity of structure and function based in this anatomic region, JAMA Otolaryngology–Head & Neck Surgery publishes clinical, translational, and population health research from an array of disciplines. We place a high priority on strong study designs that accurately identify etiologies, evaluate diagnostic strategies, and distinguish among treatment options and outcomes.2024 American Medical Association. All rights reserved, including those for text and data mining, AI training, and similar technologies. 科学 衛生・健康的な生活 身体的病い・疾患
エピソード
  • Stellate Ganglion Block for the Treatment of COVID-19−Induced Parosmia

    Stellate Ganglion Block for the Treatment of COVID-19−Induced Parosmia
    2025/08/14

    Interview with Nyssa Fox Farrell, MD, and Lara W. Crock, MD, PhD, MSCI, authors of Stellate Ganglion Block for the Treatment of COVID-19−Induced Parosmia: A Randomized Clinical Trial. Hosted by Paul C. Bryson, MD, MBA.

    Related Content:

    • Stellate Ganglion Block for the Treatment of COVID-19−Induced Parosmia
    続きを読む 一部表示
    20 分
  • Pathologic Treatment Effect and Survival in HPV-Negative HNSCC Following Neoadjuvant Nivolumab

    Pathologic Treatment Effect and Survival in HPV-Negative HNSCC Following Neoadjuvant Nivolumab
    2025/07/31

    Interview with Jennifer M. Johnson, MD, PhD and Adam J. Luginbuhl, MD authors of A Pathologic Treatment Effect and Survival in HPV-Negative HNSCC Following Neoadjuvant Nivolumab. Hosted by Paul C. Bryson, MD MBA.

    Related Content:

    • Pathologic Treatment Effect and Survival in HPV-Negative HNSCC Following Neoadjuvant Nivolumab
    • Emerging Role of Pathologic Response in Head and Neck Squamous Cell Carcinoma Immunotherapy
    続きを読む 一部表示
    18 分
  • Longitudinal Financial Toxicity and Quality of Life in Head and Neck Cancer

    Longitudinal Financial Toxicity and Quality of Life in Head and Neck Cancer
    2025/06/12

    Interview with Leila J. Mady, MD, PhD, MPH, author of Longitudinal Financial Toxicity and Quality of Life in Head and Neck Cancer. Hosted by Paul C. Bryson, MD, MBA.

    Related Content:

    • Longitudinal Financial Toxicity and Quality of Life in Head and Neck Cancer
    続きを読む 一部表示
    14 分
まだレビューはありません